Fleet Bioprocessing Ltd. are well-known worldwide for their expertise in bioconjugation chemistry, smoothly coupling molecules of interest to create powerful new entities such as antibody-enzyme conjugates. 

Their experts have worked at the cutting edge of this field since the 1980s, and their Managing Director is co-author of Bioconjugation: Protein Coupling Techniques for the Biomedical Sciences (Macmillan, 1998), a standard reference work in the field.

Within the contract R&D sphere, Fleet have unrivalled experience and knowhow in bioconjugate development. They pride themselves on the reproducibility of their conjugation methods – they routinely employ highly controllable heterobifunctional coupling chemistry allowing the greatest flexibility in achieving your product requirements. Typically they will provide your conjugate as a highly-purified product, in a buffer of your choice, with detailed incorporation information. 

Within reason they can couple anything to anything else – and as they have been told more than once by their customers, “If Fleet can’t couple it, nobody can…”

Their services include:

– Enzyme conjugates
– Biotin and streptavidin conjugates
– Fluorescent and luminescent conjugates
– Digoxigenin conjugates
– Bead and particle conjugates
– Oligonucleotide and aptamer conjugates
– Antibody-Drug Conjugates (ADCs)
– Lateral flow conjugates
– Immunogens
– Others...

If you would like to find out more information about bioconjugation, please visit Fleet Bioprocessing via the link below:

 Fleet Bioprocessing’s webpage 
– Bioconjugation -